CDKN2A and melanoma: A study of the world’s largest melanoma database showed a significant association between pancreatic cancer and CDKN2A mutation in melanoma multiplex families, with 28% of mutation-positive kindreds having pancreatic cancer as compared to 6% in patients without the mutation [37].